Akinsanya Karen O - Cardiovascular Diseases of Merck Research Laboratories, Kenilworth, NJ, USA.

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 55 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity

Alan S. Futran, Tao Lu, Katherine Amberg-Johnson, Jiayi Xu, Xiaoxiao Yang, Saidi He, Sarah Boyce,Jeffrey A. Bell,Robert Pelletier,Takao Suzuki, Xianhai Huang, Heng Qian,

iScienceno. 5 (2024): 109693

引用0浏览0引用

Enabling structure-based drug discovery utilizing predicted models

Edward B. Miller, Howook Hwang,Mee Shelley,Andrew Placzek, Joao P. G. L. M. Rodrigues, Robert K. Suto,Lingle Wang,Karen Akinsanya,Robert Abel

CELL（2024）

引用0浏览0引用

USP7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity

Alan S. Futran, Tao Lu, Katherine Amberg-Johnson, Jiayi Xu, Xiaoxiao Yang, Saidi He, Sarah Boyce,Jeffrey A. Bell, Robert Pelletier,Takao Suzuki, Xianhai Huang, Heng Qian,

iScience（2024）

引用0浏览0引用

Sgr-2921, a Potent CDC7 Inhibitor, Demonstrates Significant Anti-Leukemic Responses in Patient-Derived AML Models Representing Difficult-to-Treat Disease

Hooman Izadi, Hui Wang,Christian Atsriku, Zef Konst,Adam Levinson, Joseph Piccotti,Steven Pirie-Shepherd,Lin Tang, Dan Weiss,Karen Akinsanya,Hamish Wright,Kristian K. Jensen

BLOODno. Supplement 1 (2023): 2801-2801

引用0浏览0引用

A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of Sgr-1505 As Monotherapy in Subjects with Mature B-Cell Malignancies

Adam Olszewski, David Kahn, Brian Yoo, Joanne B. L. Tan, Vipul K. Gupta, Edgar Schuck,Zhe Nie,Goran Krilov,D. Hamish Wright, Daniel Weiss, Jean Lachowicz,Karen Akinsanya,

BLOODno. S3 (2023): e40906a2-e40906a2

引用0浏览0引用

A First-in-Human, Phase 1, Dose Escalation Study of Sgr-2921 As Monotherapy in Subjects with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome